-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

322. Hemophilia A and B: Clinical and Epidemiological: Poster II

Symposia: Hemophilia A and B: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Janice Staber, MD1, Alix Arnaud, MS2*, Ion Agirrezabal, MSc/PhD3*, Lane Anson, PharmD/MBA/RPh4*, Andrew Wilson, MS4*, Nana Kragh, MSc5*, Doris V. Quon, MD, PhD6 and Allison P Wheeler, MD/MSCI7

1Pediatrics, University of Iowa Stead Family Children's Hospital, Iowa City, IA
2Sanofi, Boston, MA
3Sanofi, Barcelona, Spain
4Sanofi, Cambridge, MA
5Sobi, Stockholm, Sweden
6Orthopaedic Institute for Children, Orthopaedic Hemophilia Treatment Center, Los Angeles, CA
7University of Washington, Washington Center for Bleeding Disorders, Seattle, WA

Midori Shima1, Katsuyuki Fukutake2*, Masanori Matsumoto3, Yoshihiko Sugimura4*, Chiaki Sugita4*, Lyu Ji4*, Mika Kawano5* and Tadashi Matsushita, MD6

1Thrombosis and Hemostasis Research Center and Department of Pediatrics, Nara Medical University, Kashihara, Japan
2Department of Blood Coagulation, Ogikubo Hospital, Tokyo, Japan
3Department of Blood Transfusion Medicine and Department of Hematology, Nara Medical University, Kashihara, Japan
4Drug Safety Division, Chugai Pharmaceutical Co., Ltd., Tokyo, Japan
5Medical Affairs Division, Chugai Pharmaceutical Co., Ltd., Tokyo, Japan
6Nagoya University Hospital, Nagoya, Japan

Valentina Restrepo, MD1, Stephanie Prozora, MD2, Evangelia Louizos3*, Layla N Van Doren, MD, MBA4 and Robert D Bona, MD5

1Section of Hematology, Yale University School of Medicine, New Haven, CT
2Department of Pediatric Hematology & Oncology, Yale University School of Medicine, New Haven, CT
3Hematology Section, Yale School of Medicine, New Haven, CT
4Section of Hematology, Division of Medicine, Yale School of Medicine, New Haven, CT
5Classical Hematology, Section of Hematology, Yale University School of Medicine, New Haven, CT

Allison P. Wheeler, MD1, Aby Abraham, MD, DM2*, Chris Barnes3*, Renée Brown Frandsen4*, Kingsley Hampton5*, Francisco José López Jaime, MD6*, Camila Martins Mazini Tavares4*, Keiji Nogami7*, Jerzy Windyga, MD, PhD8 and Giancarlo Castaman9*

1Washington Center for Bleeding Disorders, Seattle, WA
2Department of Haematology, Christian Medical College Ranipet Campus, Ranipet, India
3The Royal Children’s Hospital, Melbourne, VIC, Australia
4Novo Nordisk A/S, Søborg, Denmark
5Department of Cardiovascular Science, University of Sheffield, Sheffield, ENG, GBR
6Hemostasis and Thrombosis Unit, Málaga Regional University Hospital, IBIMA, Málaga, Spain
7Department of Pediatrics, Nara Medical University, Nara, Japan
8Laboratory of Hemostasis and Metabolic Diseases, Department of Hemostasis Disorders and Internal Medicine, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
9Center for Bleeding Disorders, Department of Oncology, Careggi University Hospital, Florence, Italy

Zhexi Lu, MD1* and Nicoletta C Machin, DO2,3

1Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA
2Division of Classical Hematology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA
3Hemophilia Center of Western Pennsylvania, Pittsburgh, PA

Aikaterini Michalopoulou, MD1*, Anna Kouramba, MD2*, Aimilia Mantzou, PhD3*, Styliani-Despoina Christidi, MD4*, Athina Dettoraki, MD, PhD1*, George Thivaios, MD4*, Zoey Kapsimali, PhD1*, Olga Katsarou Fasouli, MD, PhD2*, Ioannis Papassotiriou, PhD5 and Helen Pergantou, MD, PhD1*

1Haemophilia Centre/Haemostasis and Thrombosis Unit - Aghia Sophia Children's Hospital, Athens, Greece
2Blood Transfusion Centre, National Reference Centre for Congenital Bleeding Disorders, Laiko General Hospital, Athens, GRC
3First Department of Pediatrics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
4Trauma and Orthopaedics Department, Laiko General Hospital, Athens, Greece
5First Department of Pediatrics, National and Kapodistrian University of Athens, School of Medicine, Athens, Attica, Greece

Azusa Nagao1*, Keiji Nogami2*, Nobuaki Suzuki3*, Chiai Nagae4*, Masahiko Ando5*, Yachiyo Kuwatsuka, MD PhD5*, Daisuke Nosaka6*, Yui Kyogoku6*, Tomomi Shimura6* and Tadashi Matsushita, MD5

1Department of Pediatrics, Ogikubo Hospital, Tokyo, Japan
2Nara Medical University, Nara, Japan
3Department of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan
4Department of Pediatrics, St Marianna University School of Medicine, Kanagawa, Japan
5Nagoya University Hospital, Nagoya, Japan
6Chugai Pharmaceutical Co., Ltd., Tokyo, Japan

Guy Young, MD1, Katherine Eakle2*, Elise Lim2* and Michael Wang3*

1Children's Hospital Los Angeles, Los Angeles, CA
2Genentech, Inc., South San Francisco, CA
3University of Colorado Anschutz Medical Campus, Aurora, CO

Randolph Leiser, PhD1*, Chanchala Kaddi2*, Mengdi Tao, MS1*, Ane Salvador, PhD3*, Ekta Seth Chhabra, PhD, MSc4* and Susana Zaph, PhD1*

1Translational Disease Modelling, Data and Data Science, Sanofi, Bridgewater, United States, Bridgewater
2Sanofi, Cambridge, MA
3Rare and Neurologic Diseases, Sanofi, Cambridge, United States, Cambridge
4Global Research Lead, Rare and Neurologic Diseases, Sanofi, Cambridge

Hui Lu, PhD1*, Jenny Whitty, PhD1*, Travis Gould, PhD2, Carmine Colavecchia, PhD, PharmD2*, Josh Coulter, MA2*, Nicola Dunn, BCA, Psych Dip3*, Pratima Chowdary, MD, MRCP, FRCPath4*, Lisa J Wilcox, PhD5*, Joseph C. Cappelleri, PhD6*, Stephanie A Christopher, MA2*, Alexis Sohn, PharmD, MPH, MS2* and Brett Hauber, PhD2*

1Evidera, London, United Kingdom
2Pfizer Inc, New York, NY
3Independent Consultant, London, United Kingdom
4Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, London, United Kingdom
5Senior Director – Global Medical Affairs at Pfizer, Pfizer, Toronto, ON, Canada
6Pfizer Inc, Groton, CT

Craig Kessler, MD1, Fernando F Corrales-Medina, MD2, Pier Mannuccio Mannucci3* and Michael D Tarantino, MD4

1Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC
2Division of Pediatric Hematology-Oncology, University of Miami-Miller School of Medicine-Sylvester Cancer Center, Miami, FL
3Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi, Hemophilia and Thrombosis Center, IRCCS Ca' Granda Foundation, Milano, Italy
4Bleeding and Clotting Disorders Institute, Peoria, IL

Martin Chandler1*, Jessica Charlet, PhD, MSc, BSc2* and Tammuella Chrisentery-Singleton, MD1

1American Thrombosis and Hemostasis Network, Rochester, NY
2Bayer US LLC Pharmaceuticals, Whippany, NJ

Steven W. Pipe, MD1, Mark T Reding, MD2, Bryan Chin3*, Karen Campbell3*, Hanlan Liu, PhD3* and Wing Yen Wong, MD3

1University of Michigan, Ann Arbor, MI
2Center for Bleeding and Clotting Disorders, University of Minnesota Medical Center, Minneapolis, MN
3Be Biopharma, Cambridge, MA

*signifies non-member of ASH